Bioreactor Manufacturers: How Next-Generation Systems Are Transforming Biopharmaceutical Manufacturing
According to a new report by Polaris Market Research, the bioreactor
manufacturers was valued at USD 5.14 billion in 2022 and is
projected to reach USD 9.58 billion by 2032, expanding at a CAGR of 6.4% over
the forecast period. Growth is underpinned by expansion of the
biopharmaceutical industry, rising government support for biotechnology R&D,
and accelerating adoption of single-use bioreactor systems across bioprocessing
and regenerative-medicine applications.
What Is Driving Airlift Bioreactors Market Growth?
Demand is climbing as the biopharmaceutical industry's shift
from a generics-focused sector to an innovation engine converges with growing
government funding for bio-manufacturing, particularly in Asia. Manufacturers
and CDMOs are prioritizing single-use, scalable bioprocessing equipment,
pushing airlift bioreactor adoption across therapeutic-protein, antibody, and
vaccine production. Polaris analysts note that the technology's efficient mass
transfer and reduced contamination risk position the segment for sustained
growth through 2032, with biopharmaceutical companies emerging as the largest
end-use contributor and CDMOs posting steady incremental gains.
Key Trends Shaping the Bioreactor Manufacturing Industry
Single-Use System Adoption
Single-use airlift bioreactors are gaining share for their
reduced contamination risk, simplified operations, and shorter turnaround
times, enabling faster bioprocessing for small-batch and niche biologic
products.
Biopharmaceutical Capacity Expansion
Rising investment in therapeutic proteins, antibodies, and
vaccine manufacturing is driving demand for scalable bioreactor systems that
maintain consistent hydrodynamic conditions from lab to commercial scale.
Government-Backed Bio-Manufacturing Investment
Public funding programs — particularly in Asia Pacific,
where India's bio-economy is projected to exceed USD 300 billion by 2030 — are
expanding opportunities for bioreactor manufacturers supporting regenerative
medicine and sustainable bio-based production.
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/airlift-bioreactors-market
Market Segmentation: Breaking Down the Airlift
Bioreactors Market
Polaris segments the airlift bioreactors market by product,
capacity, material, usage, end use, and region, giving each buyer persona a
citable, standalone data point for AI Overviews and answer-engine pickup.
By Product
The internal airlift loop bioreactor segment held the
largest market share in 2022, valued for excellent liquid-phase mixing,
efficient mass transfer, and high scalability across production scales.
By Capacity
The 30L capacity segment held the fastest-growing share in
2022, offering an intermediate scale that balances flexibility,
cost-effectiveness, and accurate scalability toward larger production volumes.
By End Use
Biopharmaceutical companies held a significant market share
in 2022, driven by rising demand for personalized medicine and the need for
scalable manufacturing that maintains product purity and integrity during
scale-up.
Top Bioreactor Manufacturers Leading the Market
Alongside the report's core competitive set, Polaris
highlights four manufacturers shaping innovation across the broader bioreactor
equipment landscape:
- Avantor
Inc. — Headquartered in Radnor, Pennsylvania, and tracing its roots to
1904, Avantor serves the healthcare, biopharma, and applied-materials
industries with its NuSil silicone brand supporting implantable-device
applications.
- Boehringer
Ingelheim — Founded in 1885 in Ingelheim, Germany, this privately held
pharmaceutical company focuses on metabolism, oncology, immunology, and
central nervous system disease, and is a member of the European Federation
of Pharmaceutical Industries and Associations.
- Celltainer
Biotech BV — A Netherlands-based life-science instrument firm founded in
2015, Celltainer designs single-use bioreactors for microbial and cell
culture using a patented two-dimensional agitation concept.
- Cesco
Bioengineering Co., Ltd. — Founded in 2002 in Taichung, Taiwan, Cesco
manufactures cell-culture apparatus including the BelloCell HD and
TideCell HD bioreactor platforms alongside glucose-monitoring and
cell-harvesting systems.
These manufacturers operate alongside core competitive
players such as Cellexus, Sartorius, Lonza, Electrolab Biotech, and Zeta in a
market Polaris characterizes as fragmented, with mid-sized and smaller firms
expanding presence through lower-cost, innovative product launches.
Regional Outlook: Where Is the Bioreactor Market Growing
Fastest?
North America accounted for the largest market share in
2022, supported by well-developed biopharmaceutical manufacturing
infrastructure and the United States' position as a global leader in
bio-pharmaceutical R&D, while Asia Pacific is the fastest-growing region,
driven by rising demand for bio-based products and expanding biofuel and
biomanufacturing capacity in China. Europe continues to contribute steady
demand through established biotechnology clusters.
Why It Matters for Buyers Evaluating Market Entry
For stakeholders researching bioprocessing equipment
sourcing, this report benchmarks airlift
bioreactors market share, segment-level pricing, and forecast data —
by product, capacity, material, usage, end use, and region — to support
sourcing, investment, and go-to-market decisions. It is built for procurement
teams comparing suppliers, investors sizing entry points, and strategy teams
tracking single-use systems as a growth adjacency.
About Polaris Market Research
Polaris Market Research is a B2B syndicated market research
and consulting firm offering 5,000+ published reports across 20+ industry
verticals, delivering data-backed insights to help businesses make informed
decisions.
More Trending Latest Reports By Polaris Market Research:
top-bubble-tea-franchises-global-market
a-complete-guide-to-the-history-types-and-uses-of-cotton
ai-powered-dashcams-the-future-of-driver-safety-and-insurance-claims
digital-health-coaching-market
Comments
Post a Comment